Marketing of Clozaril
Subtitle: improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first session, on the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991.
Series: S. hrg. ;; 102-175
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1991
Place of publication: Washington
Language: eng
Number of pages: 139
Subjects: Sandoz Pharmaceuticals Corporation; Clozapine -- Marketing; Drugs -- Prices -- United States; Medical care -- United States -- Cost control
Notes: Includes bibliographical references.
"Serial no. J-102-6."